From: Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer
Group
Narrow OR stable lesions
Lesions increase
All cases
Apatinib group (n)
24
12
36
Control group (n)
32
40
72
P
0.029